Cargando…
A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression
BACKGROUND: Several studies have evaluated the efficacy and tolerability of aripiprazole for augmentation of antidepressant therapy for treatment-resistant depression (TRD). Here, we investigated the efficacy of aripiprazole augmentation for TRD including both major depressive disorder and bipolar d...
Autores principales: | Sugawara, Hiroko, Sakamoto, Kaoru, Harada, Tsuyoto, Shimizu, Satoru, Ishigooka, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869788/ https://www.ncbi.nlm.nih.gov/pubmed/27274249 http://dx.doi.org/10.2147/NDT.S104115 |
Ejemplares similares
-
A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome
por: Harada, Tsuyoto, et al.
Publicado: (2014) -
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
por: Berman, Robert M, et al.
Publicado: (2011) -
Identifying predictive clinical characteristics of the treatment efficacy of mirtazapine monotherapy for major depressive disorder
por: Tsutsumi, Takahiro, et al.
Publicado: (2016) -
Augmentation treatment in major depressive disorder: focus on aripiprazole
por: Nelson, J Craig, et al.
Publicado: (2008) -
Aripiprazole Augmentation in the Treatment of Military-Related PTSD with Major Depression: a retrospective chart review
por: Richardson, J Don, et al.
Publicado: (2011)